Skip to Main Content

Author Details

Anirban Maitra
The University of Texas MD Anderson Cancer Center
1993
617
129
PMIDPaper TitleJournal TitlePublished Year
36862364Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary.J Gastrointest Cancer2023
37721516Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.Cancer Res Commun2023
37625403Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8<sup>+</sup> T cells.Dev Cell2023
37625401KRAS<sup>G12D</sup> inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8<sup>+</sup> T cells.Cancer Cell2023
37778962Anxiolytics cause anxiety in pancreatic cancer.Trends Cancer2023
37609177Impact of <i>KRAS</i> Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Res Sq2023
37645752Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration.bioRxiv2023
35470312Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach.J Clin Gastroenterol2023
37124705Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer.Artif Intell Surg2023
37059070Pancreatic cancer: Advances and challenges.Cell2023
37285225Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential.Cancer Discov2023
37248301Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.Nat Med2023
37174073Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.Cancers (Basel)2023
37140994Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia.J Clin Invest2023
37403656From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles.Cancer Prev Res (Phila)2023
37370842Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.Cancers (Basel)2023
37001882Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.Cancer Prev Res (Phila)2023
36997301It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease.Gut2023
36585453Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.Nat Cancer2023
36746143Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.Am J Surg Pathol2023
36824971Oncogenic Kras <sup>G12D</sup> specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 <sup>+</sup> T cells dependent manner.bioRxiv2023
33978293Improvement in lung health in primary ciliary dyskinesia.J Paediatr Child Health2022
35352061Translational advances in pancreatic ductal adenocarcinoma therapy.Nat Cancer2022
35606824Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.J Hematol Oncol2022
35697807Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Nat Biotechnol2022
35666804A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma.Cancer Res2022
35491652Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.Clin Cancer Res2022
35752636Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution.Nat Commun2022
35849783Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.Cancer Discov2022
35972283Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis.Microbiol Spectr2022
36196575The Boring Schwann Cells: Tumor Me-TAST-asis along Nerves.Cancer Discov2022
35883108Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.J Hematol Oncol2022
36008214Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes.Pancreatology2022
36049831The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.Surg Pathol Clin2022
362826003D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.J Clin Invest2022
34954100Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.Contemp Clin Trials2022
35097226NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.Clin Transl Radiat Oncol2022
34980020PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.BMC Cancer2022
34973294Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.Gastroenterology2022
35120601Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.Cancer Cell2022
34971802CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop.Mol Metab2022
34905283Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.Cancer Cytopathol2022
35110355Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.J Immunother Cancer2022
35022962Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.Cancer Metastasis Rev2022
35339459Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.Gastroenterology2022
35333778Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.Clin Transl Gastroenterol2022
35323123Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic Analysis.JMIR Cancer2022
34301741Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.Thorax2022
33009500Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.Lab Invest2021
33785875Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer.Br J Cancer2021
  • 1 - 50 of 617

Recommended Authors

Julie M Wilson
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 19
Dianne Chadwick
University Health Network
Career Start Year 2013
Number of shared co-authors 17
Ashton A Connor
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 16
Gun Ho Jang
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 22
Jeran K Stratford
Research Triangle Institute (RTI)
Career Start Year 2009
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 3
Kurt W Fisher
University of Nebraska Medical Center
Career Start Year 2004
Number of shared co-authors 1
Kristopher K Frese
Cancer Research UK Manchester Institute, University of Manchester
Career Start Year 2003
Number of shared co-authors 3
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 6
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 13
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 10
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 3
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 7
Alexander D Borowsky
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 10
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 20
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 9
Michael R Emmert-Buck
The Francis Crick Institute
Career Start Year 1994
Number of shared co-authors 14
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 6
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 5
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 17
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 2
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 9
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 15
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 3
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 30
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 19
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 6

Collaborators

Richard D Schulick
University of Colorado School of Medicine
Co-authored papers 38
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Co-authored papers 22
Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 22
Bert Vogelstein
Co-authored papers 20
Kenneth W Kinzler
Co-authored papers 19
Akhilesh Pandey
Co-authored papers 17
Paola A Guerrero
The University of Texas MD Anderson Cancer Center
Co-authored papers 16
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 15
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers 14
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Co-authored papers 13
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers 13
Timothy P Heffernan
Co-authored papers 13
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 12
Nickolas Papadopoulos
Co-authored papers 11
Andrea Viale
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Victor E Velculescu
Co-authored papers 9
Jaewon J Lee
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Subrata Sen
UT MD Anderson Cancer Center
Co-authored papers 8
Daniel D Von Hoff
Co-authored papers 8
Sudhir Srivastava
National Cancer Institute
Co-authored papers 7
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Siân Jones
Co-authored papers 7
Joseph A Califano
University of California
Co-authored papers 6
Gloria M Petersen
Mayo Clinic
Co-authored papers 6
Eduardo Vilar
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 6
Prasanta Dutta
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Leslie Cope
Johns Hopkins University School of Medicine
Co-authored papers 5
Jonathan R Pollack
Stanford University School of Medicine
Co-authored papers 5
Xiaosong Zhang
Co-authored papers 5
Release 1.2